Your browser doesn't support javascript.
loading
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
Jiang, Xi; Bugno, Jason; Hu, Chao; Yang, Yang; Herold, Tobias; Qi, Jun; Chen, Ping; Gurbuxani, Sandeep; Arnovitz, Stephen; Strong, Jennifer; Ferchen, Kyle; Ulrich, Bryan; Weng, Hengyou; Wang, Yungui; Huang, Hao; Li, Shenglai; Neilly, Mary Beth; Larson, Richard A; Le Beau, Michelle M; Bohlander, Stefan K; Jin, Jie; Li, Zejuan; Bradner, James E; Hong, Seungpyo; Chen, Jianjun.
Afiliación
  • Jiang X; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. chen3jj@uc.edu jiangx4@uc.edu sphong@uic.edu.
  • Bugno J; Department of Biopharmaceutical Sciences College of Pharmacy, The University of Illinois, Chicago, Illinois.
  • Hu C; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. Department of Hematology, The First Affiliated Hospital and Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou,
  • Yang Y; Department of Biopharmaceutical Sciences College of Pharmacy, The University of Illinois, Chicago, Illinois.
  • Herold T; Department of Internal Medicine 3, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.
  • Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Chen P; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Gurbuxani S; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Arnovitz S; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Strong J; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio.
  • Ferchen K; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio.
  • Ulrich B; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Weng H; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Wang Y; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. Department of Hematology, The First Affiliated Hospital and Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou,
  • Huang H; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Li S; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Neilly MB; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Larson RA; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Le Beau MM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
  • Jin J; Department of Hematology, The First Affiliated Hospital and Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, China.
  • Li Z; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hong S; Department of Biopharmaceutical Sciences College of Pharmacy, The University of Illinois, Chicago, Illinois. Division of Integrated Science & Engineering, Underwood International College, Yonsei University, Incheon, Korea. chen3jj@uc.edu jiangx4@uc.edu sphong@uic.edu.
  • Chen J; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. chen3jj@uc.edu jiangx4@uc.edu sphong@uic.edu.
Cancer Res ; 76(15): 4470-80, 2016 08 01.
Article en En | MEDLINE | ID: mdl-27280396
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs / Proteínas de la Membrana Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs / Proteínas de la Membrana Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos